CLINICAL TRIALS PROFILE FOR LYSTEDA
✉ Email this page to a colleague
All Clinical Trials for Lysteda
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00113568 ↗ | Safety Study of XP12B in Women With Menorrhagia | Completed | Ferring Pharmaceuticals | Phase 3 | 2005-06-01 | The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia. |
NCT00386308 ↗ | Efficacy and Safety Study of XP12B in Women With Menorrhagia | Completed | Ferring Pharmaceuticals | Phase 3 | 2006-10-01 | The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia. |
NCT00401193 ↗ | Efficacy and Safety of XP12B in Women With Menorrhagia | Completed | Ferring Pharmaceuticals | Phase 3 | 2006-11-01 | The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Lysteda
Condition Name
Clinical Trial Locations for Lysteda
Trials by Country
Clinical Trial Progress for Lysteda
Clinical Trial Phase
Clinical Trial Sponsors for Lysteda
Sponsor Name